The beginning of a century of medical heritage
The General Hospital and Medical School of the Red Cross Society of China was established, beginning a tradition of patient care and medical education that continues today.
Two specialties ranked first nationally for reputation.
A century of medical advances, with innovations born in China.
Dermatology and infectious diseases ranked first in the 2023 Fudan National Specialty Reputation Rankings. From China's first surgical microscope to contralateral C7 nerve transfer, Huashan's strengths are rooted in medical breakthroughs in China.
Founded in 1907, Huashan has more than a century of history. Alongside its clinical experience, it has developed original techniques that advanced medicine: China's first surgical microscope, contralateral C7 nerve transfer, and nerve reconstruction research published in international medical journals.
Four specialties rank among the national top three for reputation, and the hospital hosts two national medical centers. Its history, specialty standing and original achievements together define Huashan's strengths.
2023 Fudan rankings
Published in November 2024
2023 national specialty reputation
2023 national specialty reputation
2023 national specialty reputation
2023 national specialty reputation
These rankings reflect national specialty reputation for the stated year, rather than overall hospital rankings or individual treatment outcomes.
National Medical Center for Neurological Diseases National Medical Center for Infectious Diseases
Covering neurosurgery, dermatology, hand surgery, infectious diseases and other clinical and professional fields.
Original research on restoring limb motor function 2023 award · Presented in 2024
The General Hospital and Medical School of the Red Cross Society of China was established, beginning a tradition of patient care and medical education that continues today.
Shi Yuquan's team developed a microscope and supporting instruments, helping Chinese neurosurgery advance into microsurgery.
Gu Yudong established a new reconstruction approach for brachial plexus root avulsion, bringing a Chinese innovation to international attention.
Xu Wendong's team received the 2023 First Prize of the National Science and Technology Progress Award for research on restoring limb motor function.
Explore Huashan Hospital's contributions in each field, from specialty standing to notable achievements, and the conditions this expertise supports.
2023 Fudan National Specialty Reputation Rankings · Neurosurgery
From pioneering microneurosurgery in China to internationally recognized brain tumor research, Huashan continues to advance surgical precision and functional preservation in complex neurological care.
Shi Yuquan's team developed a surgical microscope and supporting instruments, advancing Chinese neurosurgery toward more precise microsurgical techniques.
Wu Jinsong's team received the Congress of Neurological Surgeons (CNS) neuro-oncology award for a randomized controlled study of 3.0T intraoperative MRI.
The hospital's reported total for 2023 illustrates the scale of the specialty's clinical services.
Huashan is the principal institution, combining expertise in neurosurgery, neurology and related disciplines.
Brain tumors near language or motor areas, as well as complex skull-base or cerebrovascular lesions, require a balance between treating the lesion and preserving function. Huashan integrates intraoperative imaging, neurophysiological monitoring, awake surgery and multidisciplinary assessment into care.
Specialty reputation rankings are not outcome rankings. Surgical volume is historical data; an individual plan requires specialist assessment.
2023 Fudan National Specialty Reputation Rankings · Dermatology
Established in 1929, Huashan's dermatology department is one of the important origins of modern dermatology in China. Its heritage is reflected both in its national reputation and in the treatment approaches it has developed for difficult skin diseases.
The department's records identify suction-blister autologous epidermal grafting and tissue-engineered skin transplantation for vitiligo as firsts in China. The latter began in 2012 for difficult vitiligo affecting large areas or specific anatomical sites.
Kang Kefei and Tian Runmei proposed China's first diagnostic criteria for atopic dermatitis, known as the Kang–Tian criteria, advancing clinical recognition and diagnosis in China.
Covering atopic dermatitis, psoriasis, vitiligo, hair loss, rare inherited skin diseases and more.
Long-standing work in dermatology research and care, including the development of specialized techniques such as vitiligo surgery.
Recurrent inflammatory skin conditions, undiagnosed lesions, and long-term problems such as vitiligo or hair loss call for more specific diagnostic and treatment assessment. Specialist teams combine pathology, fungal testing, immunology and imaging to identify causes and treatment options for complex problems.
Specialty reputation rankings are not outcome rankings. Transplantation and other treatments require assessment of the condition and eligibility.
Contralateral C7 nerve transfer · Research associated with a National Science and Technology Progress First Prize
From reconnecting severed nerves to restoring upper-limb function after brain injury, Huashan's hand surgery team has extended its approach from peripheral nerves to central nervous system injury, producing original research with international influence.
Using nerves from the unaffected side to rebuild pathways on the affected side opened a treatment approach for difficult brachial plexus root avulsion and became a signature contribution of Huashan hand surgery.
Xu Wendong and Gu Yudong's team applied this approach in a randomized controlled study of upper-limb paralysis after chronic brain injury, extending nerve reconstruction research from peripheral nerve injury to brain injury.
The 2023 award, presented in 2024, recognized work on restoring limb motor function.
Original research, including contralateral C7 nerve transfer, explores clinical applications for restoring upper-limb function.
The team assesses nerve reconstruction and rehabilitation for upper-limb dysfunction caused by brachial plexus or peripheral nerve injury, and for selected cases of upper-limb paralysis after brain injury. Treatment selection considers injury location, disease duration and rehabilitation circumstances.
These reconstructive procedures have specific eligibility criteria and are not appropriate for every patient with paralysis on one side.
2023 Fudan National Specialty Reputation Rankings · Infectious Diseases
From its establishment in 1955 to becoming home to a National Medical Center for Infectious Diseases, Huashan's influence rests on long experience treating complex infections and contributions to international standards of care.
The center undertakes clinical and research work in infectious diseases, connecting pathogen identification, complex infection assessment and antimicrobial treatment.
Professor Zhu Liping contributed to the global guideline for the diagnosis and management of candidiasis, bringing Huashan's experience in fungal infections into international academic collaboration.
Established at Huashan in 2021 to support clinical care and research in infectious diseases.
Combining molecular diagnostics, microbiological testing, medication management and multidisciplinary clinical experience.
Prolonged unexplained fever, an inadequate response to standard antimicrobial treatment, or infections involving the central nervous system, resistant bacteria or invasive fungi require pathogen testing and multidisciplinary judgment to identify the cause and refine treatment.
Specialty reputation rankings are not outcome rankings. Acute high fever, altered consciousness and other emergencies require prompt local medical care.
2023 Fudan National Specialty Reputation Rankings · Neurology
Founded in 1950, it is among China's earliest neurology departments. From training neurologists across the country to contributing to international diagnostic consensus, Huashan has long focused on Parkinson's disease, cognitive disorders and other complex neurological diseases.
Professor Zhang Yuanchang founded the department. In 1981 it became one of China's first institutions authorized to award doctorates in neurology, continuing to train specialists in neurological diseases.
Wang Jian, Zuo Chuantao and an international team developed the consensus, helping standardize molecular brain imaging for Parkinson's disease and related disorders to support differential diagnosis.
Established in 2021, the center combines online and in-person services to connect assessment with long-term management.
Connecting assessments from neurology, neurosurgery, imaging, rehabilitation and other specialties.
Hand tremor and slow movement do not always have the same cause. For Parkinson's disease and related syndromes, dystonia and cognitive disorders, specialist teams combine clinical assessment, imaging and long-term follow-up to connect diagnosis, medication and evaluation for neuromodulation.
Specialty reputation rankings are not outcome rankings. Suitability for medication, neuromodulation or other treatment requires specialist assessment.
Discover the specialists' contributions and the conditions and treatments they focus on.
Showing 5 representative specialists
Neurosurgery
Chief physician · Professor Doctoral supervisor
Recipient of the National Science Fund for Distinguished Young Scholars
Ministry of Education Changjiang Distinguished Professor
His work centers on cerebral revascularization and brain tumor care, bringing together surgical innovation, individualized surgical planning and clinical research.
As the first-ranked contributor, he led a project on basic and clinical innovations in surgically modifying cerebral blood flow, addressing difficult brain aneurysms and moyamoya disease. The award was presented in 2018.
Fudan's account of his achievements credits him with leading China's first glioma diagnosis and treatment guideline and publishing molecular guidelines for glioma care, supporting individualized treatment.
He undertook training in cerebrovascular and skull-base surgery at Osaka City University in Japan and Massachusetts General Hospital, Harvard University, in the United States, and postdoctoral research on cerebral ischemia at the University of Michigan. His personal role in awards and the achievements of teams he led are identified separately above.
Dermatology
Chief physician Doctoral supervisor
Drafting expert for China's acne treatment guideline
Former president of the Asian Society for Pigment Cell Research
She focuses on pigmentary disorders such as vitiligo and melasma, while also treating acne, facial dermatitis and eczema, bringing clinical experience into care standards and international academic exchange.
She is credited as a drafting expert in the Chinese Guidelines for the Management of Acne (2014 Revision), published in the Journal of Clinical Dermatology in 2015, contributing to standardized acne care.
Fudan's 2018 report records her previous roles as president of the Asian Society for Pigment Cell Research (ASPCR) and vice president of the Chinese Dermatologist Association.
Her hospital profile lists pigmentary, aesthetic and allergic skin disorders among her areas of expertise. The academic offices shown here are historical appointments and do not establish that she currently holds them. The scope of consultations depends on hospital arrangements.
Hand surgery
Chief physician · Professor Doctoral supervisor
First-ranked contributor to a National Science and Technology Progress First Prize
Selected as a New Cornerstone Investigator in 2023
He has long studied neural plasticity and limb reconstruction, working with Academician Gu Yudong and others to advance clinical research and application of nerve-transfer techniques pioneered in China.
As the first-ranked contributor, he led a project on restoring limb motor dysfunction through peripheral–central neural pathways. The award was presented in 2024.
He and his team studied contralateral C7 nerve transfer for upper-limb paralysis after chronic brain injury. The research was published in the New England Journal of Medicine and selected among its most notable studies of 2018.
In 2023 he joined the second cohort of New Cornerstone Investigators and the first cohort of Fudan Xianghui Scholars. Nerve transfer and functional reconstruction have specific indications and require assessment of disease duration, nerve function and rehabilitation circumstances; they are not suitable for every patient with paralysis on one side.
Infectious diseases
Head of Infectious Diseases · Professor Doctoral supervisor
Director of the National Medical Center for Infectious Diseases
Ask about this doctorHis long-standing clinical and research work in infectious diseases covers fever of unknown origin, complex infections, chronic hepatitis, cirrhosis and abnormal liver function.
As director of the National Medical Center for Infectious Diseases and head of Huashan's infectious diseases department, he leads the development of clinical and research teams.
He led a project on public engagement in pandemic response and healthy living during COVID-19, receiving the 2022 Grand Prize, presented in 2023. This achievement is in science communication.
His hospital profile specifically lists the personal clinical areas above. The department also has teams focused on particular infections; its full service range should not be taken as his individual consultation scope. Acute high fever, altered consciousness and other emergencies require prompt local care.
Neurology
Chief physician · Professor Doctoral supervisor
Head of Neurology, Huashan Hospital
Chief scientist of a national major research project
His research covers differential diagnosis, molecular brain imaging and long-term treatment in Parkinson's disease, connecting clinical care, international expert consensus and national research projects.
He is chief scientist of a Parkinson's disease project under the national major science and technology program for Brain Science and Brain-Inspired Research, organizing research in this area.
Together with international experts, he developed consensus on the clinical use of dopaminergic PET imaging in Parkinson-related diseases to standardize testing and interpretation. It appeared online in 2023 and in print in 2024.
He undertook postdoctoral research at the University of Pittsburgh's center for Parkinson's disease and other neurodegenerative disorders. Trials of new drugs and gene therapies in which he participates are research; they do not imply routine treatment availability or direct eligibility for enrollment.
These profiles describe professional expertise and notable experience. The doctor, campus and appointment time are confirmed when arranging care.
Tell eastmedgo about the specialty, doctor or care question that matters to you, through WhatsApp or email.
Initial service inquiries are free. Medical assessments and treatment recommendations are provided by the receiving hospital and doctors.